Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
Clinical trial NCT04108624 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04108624
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2028-04-26
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.